Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Phase Ii, Safety and Immunogenicity of Razi Cov Pars (Rcp) Sars Cov-2 Vaccine in Adults Aged 18–70 Years; a Randomized, Double-Blind Clinical Trial
Maryam Albaji
Maryam Albaji

Assistant Professor of Pulmonary Diseases

Department Internal Medicine

School of Medicine

Sina Hospital

Tehran University of Medical Sciences

Related Documents
1. Severity of Sars-Cov-2 Reinfection in Vaccinated Healthcare Workers, Iranian Journal of Microbiology (2023)